Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome: Current and Novel Therapies

NCT02378805 is registered in ClinicalTrials.gov with University Hospital Goettingen as lead sponsor.

NCT NCT02378805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02378805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome: Current and Novel Therapies
Lead sponsor
University Hospital Goettingen
Phase
Observational
Overall status
Recruiting
Start date
July 31, 1995
Completion date
March 1, 2036
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alport syndrome, familial benign hematuria, hereditary kidney disease, pediatric kidney disease, thin basement membrane disease